||
自从2007年发现氢气治疗疾病的效应后,饮用含氢气水作为治疗疾病的方法已经开展了15项小规模的临床研究,这些临床研究总患者数量达到309人。虽然规模不大,但是也初步确定了氢气水对人体的安全性,初步证明对某些疾病如对帕金森病、代谢综合症、糖尿病、类风湿关节炎、运动疲劳和肌肉病等具有治疗效果。这些研究给将来更大规模的多中心双盲对照研究奠定了重要基础。如日本军医大学已经计划开展对蛛网膜下腔出血的大规模临床研究。
目前关于氢气的临床研究多数来自日本,中国的研究只有2篇,这和中国学者发表大量基础研究论文和承担大量国家自然科学基金的情况相比,显然非常不正常。
为什么中国学者在氢气临床研究方面相对不足?个人认为,一方面是因为大家对这个新的概念认识不足。另外一个方面是,缺少大的企业推动,临床研究需要的比较多的研究经费,没有大的经费支持,很难开展比较大规模的临床研究,这方面日本的情况相对好一些。再次是许多人对开展这类临床研究存在误区,例如有的人觉得氢气产品没有得到国家卫生机构的认可,能不能进行临床研究,这显然是对开展临床研究的基本条件不够了解造成。
文献列表
编号 | 疾病 | 设计 | 患者数 | 体积 (ml) | 浓度 ppm | 治疗周 | 文献 |
1 | Parkinson's disease | Double blind RCT | 19 | 1000 | 1.6 | 56 | Yoritaka, et al., [1] |
2a | Myopathies
| Open label trial | 14 | 1000 | 1 | 12 | Ito, et al., [2] |
2b | Myopathies
| Double blind Crossover RCT | 22 | 500 | 1 | 8 | Ito, et al., [2] |
3a | Diabetes mellitus type 2 | Double blind Crossover RCT | 30
| 900 | 1.2 | 8 | Kajiyama, et al., [3] |
3b | Glucose intolerance | Double blind Crossover RCT | 6 | 900 | 1.2 | 8 | Kajiyama, et al., [3] |
4a | Metabolic syndrome | Open label trial | 20 | 1500-2000 | 1.2 | 8 | Nakao, et al.,[4] |
4b | Metabolic syndrome | Open label trial | 20 | 900-1000 | 0.20-0.25 | 10 | Song, et al.,[5] |
5a | Hemodialysis | Open label trial | 8 | hemodialysis | 0.048 | 4 | Nakayama, et al., [6] |
5b | Hemodialysis | Open label trial | 21
| hemodialysis | 0.21 | 26 | Nakayama, et al., [7] |
6 | Radiation side effects
| RCT but not blinded | 49 | 1500-2000
| 1.1-1.
| 3 6
| Kang, et al.,[8] |
7 | Brain stem infarction | Open label trial | 34 | Drip infusion | 1.6 | 1 | Ono, et al.,[9] |
8 | Muscle fatigue
| Double blind Crossover RCT | 10
| 1500 | 1.2 | Once | Aoki, et al., [10] |
9 | Rheumatoid arthritis | Open label trial | 20 | 530 | 5-Apr | 4 | Ishibashi, et al., [11] |
10 | Interstitial cystitis/painful bladder syndrome | Double blind RCT | 30 | 600 | 1.2 | 8 | Matsumoto, et al., [12] |
11 | Peritoneal deterioration |
| 6
| Peritoneal dialysis | 1.2 |
| Terawaki, et al., [13] |
| Trial RCT: Randomized Controlled |
参考文献
1. Yoritaka A, Takanashi M, Hirayama M, Nakahara T, OhtaS, et al. (2013) Pilot study of Ha‚‚ therapy inParkinson's disease: a randomized doubleblind placebo-controlled trial. MovDisord 28: 836-839.
2. Ito M, Ibi T, Sahashi K, Ichihara M, Ito M, et al. (2011) Open-label trial and randomized, double-blind, placebo-controlled, crossover trial of hydrogen-enriched water for mitochondrial andinflammatory myopathies. Med Gas Res 1: 24.
3. Kajiyama S, Hasegawa G, Asano M, Hosoda H, Fukui M, etal. (2008) Supplementation of hydrogen-richwater improves lipid and glucose metabolism in patients with type 2 diabetes orimpaired glucose tolerance. Nutr Res 28: 137-143.
4.Nakao A, Toyoda Y, Sharma P, Evans M, Guthrie N (2010)Effectiveness of hydrogen rich water on antioxidant status of subjects withpotential metabolic syndrome-an open label pilot study. J Clin Biochem Nutr 46:140-149.
5. Song G, Li M, Sang H, Zhang L, Li X, et al. (2013)Hydrogen-rich water decreases serum LDL-cholesterol levels and improves HDLfunction in patients with potential metabolic syndrome. J Lipid Res 54:1884-1893.
6.Nakayama T, Koga K, Tanaka H (2009) Augmented stabilityof hydrogen clathrate hydrates by weakly polar molecules. J Chem Phys 131:214506.
7. Nakayama M, Nakano H, Hamada H, Itami N, Nakazawa R,et al. (2010) A novel bioactive haemodialysis system using dissolved dihydrogen(H2) produced by water electrolysis: a clinical trial. Nephrol Dial Transplant 25:3026-3033.
8. Kang KM, Kang YN, Choi IB, Gu Y, Kawamura T, et al.(2011) Effects of drinking hydrogen-rich water on the quality of life ofpatients treated with radiotherapy for liver tumors. Med Gas Res 1: 11.
9. Ono H, Nishijima Y, Adachi N, Tachibana S, Chitoku S,et al. (2011) Improved brain MRI indices in the acute brain stem infarct sitestreated with hydroxyl radical scavengers, Edaravone and hydrogen, as compared toEdaravone alone. A non-controlled study. Med Gas Res 1: 12.
10. Aoki K, Nakao A, Adachi T, Matsui Y, Miyakawa S(2012) Pilot study: Effects of drinking hydrogen-rich water on muscle fatiguecaused by acute exercise in elite athletes. Med Gas Res 2: 12.
11. Ishibashi T, Sato B, Rikitake M, Seo T, Kurokawa R,et al. (2012) Consumption of water containing a high concentration of molecularhydrogen reduces oxidative stress and disease activity in patients with rheumatoidarthritis: an open-label pilot study. Med Gas Res 2: 27.
12. Matsumoto S, Ueda T, Kakizaki H (2013) Effect ofsupplementation with hydrogen-rich water in patients with interstitialcystitis/painful bladder syndrome. Urology 81: 226-230.
13.Terawaki H, Hayashi Y, Zhu WJ, Matsuyama Y, Terada T,et al. (2013) Transperitoneal administration of dissolved hydrogen forperitoneal dialysis patients: a novel approach to suppress oxidative stress inthe peritoneal cavity. Med Gas Res 3: 14.
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-8-18 00:17
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社